Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223870 · ClinicalTrials.gov registry record
Respiratory Rate Accuracy - Healthy Adults
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 30
- Enrollment target
NCT03223870: Completed study, sponsored by Nonin Medical.
NCT03223870 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03223870 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the Fingertip Respiratory Rate algorithm performance of the Nonin Medical X-100SP pulse oximetry systems with the 8300AA sensors and Onyx 3 fingertip oximeter. There is no treatment or interventions being performed.
Primary Outcome
Values from the test device will be compared to the values from co-oximetry devices
Interventions
- DIAGNOSTIC_TEST Diagnostic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-07-11 |
| Est. Completion | 2017-07-31 |
What the finished NCT03223870 record still lists
NCT03223870 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic is the first listed.
NCT03223870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03223870 about?
NCT03223870 is a clinical study titled "Respiratory Rate Accuracy - Healthy Adults". The objective of this study is to evaluate the Fingertip Respiratory Rate algorithm performance of the Nonin Medical X-100SP pulse oximetry systems with the 8300AA sensors and Onyx 3 fingertip oximeter. There is no treatment or interventions being performed.
What is the current status of trial NCT03223870?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-07-11. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT03223870?
The interventions under investigation include: Diagnostic (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03223870?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI